Ligand

New Paper in Science Reports Discovery of Ultrapotent Chemogenetic Approach that Forms Scientific Foundation for Redpin Therapeutics’ Technology

Retrieved on: 
Thursday, March 14, 2019

Scott Sternson, Ph.D., Group Leader at the Janelia Research Campus of the Howard Hughes Medical Institute (HHMI), led the study.

Key Points: 
  • Scott Sternson, Ph.D., Group Leader at the Janelia Research Campus of the Howard Hughes Medical Institute (HHMI), led the study.
  • Redpin Therapeutics has a worldwide exclusive license from HHMI for therapeutic use of this technology.
  • The researchers developed a novel method for engineering ligand-gated ion channel receptors to have ultrapotent sensitivity to U.S. Food and Drug Administration (FDA)-approved agonists.
  • These chemogenetic receptors enable the selective control of cells in vivo, which Redpin is developing for potential clinical therapies.

Hello Bio Launches Novel Water-soluble, High Potency DREADD Ligands, Licensed from the NIH

Retrieved on: 
Saturday, March 9, 2019

PRINCETON, N.J., March 09, 2019 /PRNewswire-PRWeb/ -- Hello Bio announces the launch of novel water-soluble and highly potent hM3Dq & hM4Di ligands exciting compounds for scientists studying GPCR and DREADD signalling.

Key Points: 
  • PRINCETON, N.J., March 09, 2019 /PRNewswire-PRWeb/ -- Hello Bio announces the launch of novel water-soluble and highly potent hM3Dq & hM4Di ligands exciting compounds for scientists studying GPCR and DREADD signalling.
  • JHU37160 dihydrochloride and JHU37152 dihydrochloride are novel DREADD ligands with high potency at hM3Dq and hM4Di DREADDs in in vitro functional assays.
  • They are active in vivo, following ip administration, and are available from Hello Bio as both the water-soluble dihydrochloride salts, and freebase forms.
  • Hello Bio was founded by a team of experienced scientists and chemists who genuinely want to support life science research.

Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules

Retrieved on: 
Monday, June 11, 2018

Molecular simulation of protein-ligand complexes was also used to understand how structural modifications might modify a ligand's activity profile.

Key Points: 
  • Molecular simulation of protein-ligand complexes was also used to understand how structural modifications might modify a ligand's activity profile.
  • "This effort led by the University of Bristol will enable Achieve to pursue the development of next-generation cytisine treatments, which will be highly-targeted and more potent.
  • The full publication, Unlocking Nicotinic Selectivity via Direct CH Functionalization of ()-Cytisine, is available via Open Access and can be viewed at https://doi.org/10.1016/j.chempr.2018.05.007 .
  • Two prior, large-scale Phase 3 clinical studies of cytisine, with favorable outcomes, have been successfully completed in over 2,000 patients.

Green Science Alliance Co., Ltd. Has Started the Manufacturing and Custom Synthesis of a Metal Organic Framework (MOF), Porous Coordination Polymers (PCPs)

Retrieved on: 
Tuesday, May 8, 2018

KAWANISHI, Japan, May 8, 2018 /PRNewswire/ --Metal organic frameworks (MOFs), also known as porous coordination polymers (PCPs), are materials composed of metal cations and polydentate ligands that bridge component metals.

Key Points: 
  • KAWANISHI, Japan, May 8, 2018 /PRNewswire/ --Metal organic frameworks (MOFs), also known as porous coordination polymers (PCPs), are materials composed of metal cations and polydentate ligands that bridge component metals.
  • MOFs are synthesized as superporous materials by modifying their metal and organic ligand, as well as the shape and size of pores.
  • Because MOFs are completely new inorganicorganic hybrid self-organized porous materials, the chemical industry has recently been highly focused on them.
  • The conventional porous materials such as zeolite, activated carbon, and porous silica have been used as catalysts, separators, adsorbents, impurity removers for water, and deodorizing materials.